⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GILD News
Gilead Sciences Inc
3T Biosciences Appoints Rebeca Villarreal-Barragan, MBA, as Head of Clinical Operations
businesswire.com
GILD
LAVERNE COX & AMBER RILEY JOIN THE ELIZABETH TAYLOR AIDS FOUNDATION AHEAD OF FEB. 28 HIV IS NOT A CRIME AWARENESS DAY
prnewswire.com
GILD
PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race
globenewswire.com
MDBH
LLY
NVO
PFE
AZN
GILD
GPCR
insitro Appoints Joe Hand as Chief People Officer to Advance Talent Strategy for Next Stage of Development
businesswire.com
AMGN
LLY
GILD
The International Myeloma Foundation Invites the Myeloma Community to Demonstrate the Spirit of #MoreThanMyeloma for 2026 Myeloma Action Month
globenewswire.com
GSK
JNJ
PFE
REGN
SNY
AMTX
ATHA
TMO
GILD
genOway : révolutionner la prédiction des thérapies à base d'anticorps chez l'humain grâce à un modèle murin unique USA - Français USA - español USA - English Japan - Japanese USA - Deutsch
prnewswire.com
VIR
GILD
Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy
businesswire.com
GILD
SPARK NS Selects Nine Projects to Receive in Total Up to $18 Million in Funding to Advance Academic Discoveries in Autism and Parkinson’s Disease from the Lab to the Clinic
globenewswire.com
NVS
MRK
BMY
LLY
ABBV
JNJ
AZN
GILD
BIIB
REGN
AMGN
VRTX
“Source of Good” Season 3 Features Global Supply Chain Voices
accessnewswire.com
UA
RL
GES
REI
GILD
Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge
prnewswire.com
MRK
EXEL
LLY
ONCY
GILD